|Articles|March 24, 2015

PHT Adopts Vodafone M2M Tech

Author(s)Applied Clinical Trials Editorial Staff

Vodafone’s Machine-to-Machine (M2M) technology enables PHT Corporation to more efficiently manage worldwide clinical trials through real-time access to patient experience data

Vodafone and PHT Corporation, a provider of technologies used to collect electronic data for clinical research from patients, will connect the PHT electronic clinical outcome assessment (eCOA) system to Vodafone’s global M2M network. Using Vodafone’s global M2M network, PHT can provide pharmaceutical trial sponsors real-time access to patient data. Currently the PHT eCOA System is used to collect data in clinical trials in more than 75 countries.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.